XORI

Details for Australian Trade Mark No. 1421974 (hide)

Owner XORI Corporation

Convention US 6 August 2010 85102251

Filing Date 5 January 2011

Classes

Class 42 Scientific research and development; research and development in the pharmaceutical and biotechnology fields; scientific, biological and medical research related to the discovery and development of monoclonal antibodies for therapeutic, diagnostic and research purposes; biochemical development of monoclonal antibodies for therapeutic, diagnostic and research purposes; development of drugs and therapeutics for research, diagnosis, and the treatment of a wide variety of diseases and other conditions, including cancer, immune disorders and infectious diseases

Event Publications

19 May 2011 Application filed

21 July 2011 Application Accepted

3 November 2011 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1421975

1421973